Financial Architecture

High‑margin SaaS wedge → usage-based data platform → underwriting leverage. Compounding expansion without linear headcount dependency.

Current (Phase 1)
  • SaaS: $50 / employee / month
  • Minimal deployment cost (self‑serve + assisted)
  • Payback period: < 3 months (pilot economics)
Expansion (Phase 2)
  • API usage fees (data enrichment & insight access)
  • Third‑party activation increases LTV without CAC
  • Partner-driven integration revenue layer
Leverage (Phase 3)
  • Payer / insurer shared savings programs
  • PMPM + outcomes-based incentive economics
  • Risk-adjusted underwriting innovation
Use of Capital
  • Data ingestion & ontology depth
  • Ecosystem partner integrations
  • Predictive clinical validation loops
ARR & Mix Projection (Insert Stacked Curve)
$4.3T
US healthcare spend (annual)
$1.2T
Preventable cost opportunity
$13.6B
Corporate wellness market
Sources

CMS National Health Expenditure; KFF/CDC prevention estimates; industry market reports (2024–2025).

Economic Thesis

As prevention shifts from aspiration to actuarial input, those who control validated behavioral outcome data control pricing power. We are building that asset.